` 603716 (Thalys Medical Technology Group Inc) vs Shanghai Composite Comparison - Alpha Spread

603716
vs
S
Shanghai Composite

Over the past 12 months, Thalys Medical Technology Group Inc has significantly outperformed Shanghai Composite, delivering a return of +103% compared to the Shanghai Composite's +22% growth.

Stocks Performance
603716 vs Shanghai Composite

Loading
603716
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
603716 vs Shanghai Composite

Performance Gap Between 603716 and SSEC
HIDDEN
Show

Performance By Year
603716 vs Shanghai Composite

Loading
603716
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Thalys Medical Technology Group Inc vs Peers

Shanghai Composite
603716
RYI
AVGR
BROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Thalys Medical Technology Group Inc
Glance View

Market Cap
4.6B CNY
Industry
Biotechnology

Thalys Medical Technology Group, Inc. engages in the research, development, production, and sale of in vitro diagnostic products. The company is headquartered in Wuhan, Hubei and currently employs 1,637 full-time employees. The company went IPO on 2016-10-31. Its product type includes purchased reagents and consumables, self-produced reagents and consumables, as well as purchased equipment. The firm mainly operates its business in domestic markets, with Hubei, Hunan, Jiangsu, Henan and Shanghai province as its major markets.

Thalys Medical Technology Group Inc Intrinsic Value
HIDDEN
Show
Back to Top